← Open Payments lookup

CECILY BOSMA: Open Payments

NPI 1063468338 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$779 in 37 payments from 9 companies in 2025. Trend: 2023 $436 · 2024 $617 · 2025 $779

Food & beverage: $779
CompanyPaymentsAmount
Abbott Laboratories14$183
Xeris Pharmaceuticals, Inc.7$159
Tandem Diabetes Care, Inc.2$123
Sequel Med Tech, LLC5$102
GlaxoSmithKline, LLC.3$71
Antares Pharma, Inc.2$58
SANOFI-AVENTIS U.S. LLC2$39
BETA BIONICS, INC.1$29
Dexcom, Inc.1$16

Products named: FREESTYLE LIBRE 3, RECORLEV, t:slim X2 Insulin Pump with Control-IQ, TWIIST, BENLYSTA, XYOSTED, TZIELD, iLet Bionic Pancreas.

Industry payments across CA — which companies pay providers there.